OWCP (OWC Pharmaceutical Research) Total Inventories: $0.00 Mil (As of Sep. 2019)


What is OWC Pharmaceutical Research Total Inventories?

OWC Pharmaceutical Research OWCP -90.00% Total Inventories is $0.00 Mil as of Sep. 2019.

OWC Pharmaceutical Research's total inventories for the quarter that ended in Sep. 2019 was $0.00 Mil. OWC Pharmaceutical Research's average total inventories from the quarter that ended in Jun. 2019 to the quarter that ended in Sep. 2019 was $0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. OWC Pharmaceutical Research's Net-Net Working Capital per share for the quarter that ended in Sep. 2019 was $-0.02.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

OWC Pharmaceutical Research  (OTCPK:OWCP) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

OWC Pharmaceutical Research's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2019 is

Net-Net Working Capital Per Share (Q: Sep. 2019 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1.465+0.75 * 0+0.5 * 0-5.781
-0-0)/244.478
=-0.02

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

OWC Pharmaceutical Research's Days Inventory for the three months ended in Sep. 2019 is calculated as:

Days Inventory=Average Total Inventories (Q: Sep. 2019 )/Cost of Goods Sold (Q: Sep. 2019 )*Days in Period
=0/0*365 / 4
=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

OWC Pharmaceutical Research's Inventory Turnover for the quarter that ended in Sep. 2019 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Sep. 2019 ) / Average Total Inventories (Q: Sep. 2019 )
=0 / 0
=N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

OWC Pharmaceutical Research's Inventory to Revenue for the quarter that ended in Sep. 2019 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Sep. 2019 ) / Revenue (Q: Sep. 2019 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

OWC Pharmaceutical Research Total Inventories Related Terms

OWC Pharmaceutical Research Total Inventories Historical Data

* Premium members only.

The historical data trend for OWC Pharmaceutical Research's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OWC Pharmaceutical Research Total Inventories Chart

OWC Pharmaceutical Research Annual Data
Trend Dec08 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Total Inventories
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

OWC Pharmaceutical Research Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OWC Pharmaceutical Research Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of $0.00 Mil mean?
OWC Pharmaceutical Research (OWCP) has a Total Inventories of $0.00 Mil as of Sep. 2019. The total amount of inventory as recorded on a company's balance sheet. View historical data for OWC Pharmaceutical Research and its competitors.
Is OWC Pharmaceutical Research's Total Inventories too high?
OWC Pharmaceutical Research's current Total Inventories is $0.00 Mil.
How does OWC Pharmaceutical Research's Total Inventories compare to PARNF and CANB?
OWC Pharmaceutical Research's Total Inventories of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Drug Manufacturers company?
A good Total Inventories depends on the Drug Manufacturers industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for OWC Pharmaceutical Research and its competitors. OWC Pharmaceutical Research's current Total Inventories is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OWC Pharmaceutical Research stock overvalued right now?
OWC Pharmaceutical Research (OWCP) has a current Total Inventories of $0.00 Mil. The current Total Inventories is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For OWC Pharmaceutical Research (OWCP), the current Total Inventories is $0.00 Mil as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OWC Pharmaceutical Research Business Description

Address 2 Ben Gurion Street, Ramat Gan, ISR, 4514760
OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders. It also provides consulting services to governmental and private entities to assist them with developing and implementing tailor-made medical cannabis program.